Andrew R Clamp Selected Research

Breast Neoplasms (Breast Cancer)

1/2019

Prevalence of germline pathogenic BRCA1/2 variants in sequential epithelial ovarian cancer cases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew R Clamp Research Topics

Disease

18	Ovarian Neoplasms (Ovarian Cancer) 05/2024 - 06/2005
15	Carcinoma (Carcinomatosis) 01/2023 - 03/2005
12	Neoplasms (Cancer) 01/2023 - 06/2005
9	Ovarian Epithelial Carcinoma 10/2023 - 01/2019
2	Fatigue 05/2024 - 01/2023
2	Disease Progression 01/2020 - 01/2011
2	Colorectal Neoplasms (Colorectal Cancer) 05/2014 - 11/2009
1	Fistula 05/2024
1	Anemia 01/2023
1	Nausea 01/2023
1	Fallopian Tube Neoplasms 02/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Proteinuria 05/2014
1	Hypertension (High Blood Pressure) 05/2014
1	Prostatic Neoplasms (Prostate Cancer) 02/2010
1	Neoplasm Metastasis (Metastasis) 11/2009
1	Pathologic Neovascularization 12/2006
1	Endometrial Neoplasms (Endometrial Cancer) 11/2005
1	Adenocarcinoma 06/2005

Drug/Important Bio-Agent (IBA)

16	PlatinumIBA 05/2024 - 01/2011
8	Paclitaxel (Taxol)FDA LinkGeneric 05/2024 - 02/2019
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2024 - 11/2005
7	Biomarkers (Surrogate Marker)IBA 11/2022 - 06/2005
6	Bevacizumab (Avastin)FDA Link 01/2023 - 09/2007
6	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023 - 01/2018
6	rucaparibIBA 12/2022 - 01/2020
4	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 12/2019
3	AntigensIBA 01/2023 - 01/2011
2	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 01/2023
2	olaparibIBA 01/2023 - 01/2023
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 11/2020 - 10/2020
2	Cisplatin (Platino)FDA LinkGeneric 02/2019 - 01/2018
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 11/2005 - 06/2005
1	cediranib (AZD2171)IBA 05/2024
1	vistusertibIBA 01/2023
1	Formaldehyde (Formol)FDA Link 01/2023
1	ParaffinIBA 01/2023
1	Peptides (Polypeptides)IBA 01/2022
1	paragonIBA 10/2021
1	Poly Adenosine Diphosphate RiboseIBA 01/2021
1	pazopanib FDA Link 01/2020
1	fosbretabulin (combretastatin A4)IBA 01/2020
1	chemotactic factor inactivatorIBA 01/2020
1	Gemcitabine FDA Link 02/2019
1	antineoplaston A10 (A 10)IBA 01/2019
1	Etoposide (VP 16)FDA LinkGeneric 01/2018
1	Tyrosine Kinase InhibitorsIBA 05/2014
1	Angiogenesis InhibitorsIBA 05/2014
1	Hormones (Hormone)IBA 02/2010
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2007
1	Sorafenib (BAY 43-9006)FDA Link 09/2007
1	Sunitinib (Sutent)FDA Link 09/2007
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2005
1	OligosaccharidesIBA 11/2005
1	CytokinesIBA 06/2005
1	Heparitin Sulfate (Heparan Sulfate)IBA 06/2005
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 03/2005

Therapy/Procedure

17	Therapeutics 01/2023 - 09/2007
12	Drug Therapy (Chemotherapy) 05/2024 - 09/2007
2	Intravenous Infusions 01/2022 - 02/2019
2	Cytoreduction Surgical Procedures 01/2021 - 01/2020
2	Home Parenteral Nutrition 01/2020 - 12/2019
1	Retreatment 01/2023
1	Neoadjuvant Therapy 01/2021
1	Ligation 01/2019